Hypertensive Crisis in Children

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2011 Jul 21

PMID 21773822

Citations 31

Authors

Jayanthi Chandar

Gaston Zilleruelo

Affiliations

Soon will be listed here.

Abstract

Hypertensive crisis is rare in children and is usually secondary to an underlying disease. There is strong evidence that the renin-angiotensin system plays an important role in the genesis of hypertensive crisis. An important principle in the management of children with hypertensive crisis is to determine if severe hypertension is chronic, acute, or acute-on-chronic. When it is associated with signs of end-organ damage such as encephalopathy, congestive cardiac failure or renal failure, there is an emergent need to lower blood pressures to 25-30% of the original value and then accomplish a gradual reduction in blood pressure. Precipitous drops in blood pressure can result in impairment of perfusion of vital organs. Medications commonly used to treat hypertensive crisis in children are nicardipine, labetalol and sodium nitroprusside. In this review, we discuss the pathophysiology, differential diagnosis and recent developments in management of hypertensive crisis in children.

Citing Articles

Clinical guidelines for the diagnosis, evaluation, and management of hypertension for Korean children and adolescents: the Korean Working Group of Pediatric Hypertension.

Park S, An H, Kim S, Kim S, Cho H, Kim J Kidney Res Clin Pract. 2025; 44(1):20-48.

PMID: 39923806 PMC: 11864819. DOI: 10.23876/j.krcp.24.096.

International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.

Casey R, Hendriks E, Deal C, Waguespack S, Wiegering V, Redlich A Nat Rev Endocrinol. 2024; 20(12):729-748.

PMID: 39147856 DOI: 10.1038/s41574-024-01024-5.

Managing severe hypertension in children.

Coulthard M Pediatr Nephrol. 2023; 38(10):3229-3239.

PMID: 36862252 PMC: 10465398. DOI: 10.1007/s00467-023-05896-z.

Prevalence of arterial hypertension in pediatric hospitalized patients.

Chacon-Jaimes D, Morales-Contreras C, Abad J, Nino-Serna L, Velez-Echeverri C Arch Cardiol Mex. 2023; 93(1):13-21.

PMID: 36757775 PMC: 10161844. DOI: 10.24875/ACM.21000362.

Hypertension crisis as the first symptom of renovascular hypertension in children.

Xu L, Ba H, Jiang X, Qin Y Ital J Pediatr. 2022; 48(1):191.

PMID: 36461036 PMC: 9717483. DOI: 10.1186/s13052-022-01378-4.

References

Calenda E, Richez F, Muraine M . Acute hypertension due to phenylephrine eyedrops in a newborn. Can J Ophthalmol. 2007; 42(3):486. DOI: 10.3129/can j ophthalmol.i07-060. View

Lurbe E, Cifkova R, Cruickshank J, Dillon M, Ferreira I, Invitti C . Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009; 27(9):1719-42. DOI: 10.1097/HJH.0b013e32832f4f6b. View

Houston M . Pathophysiology, clinical aspects, and treatment of hypertensive crises. Prog Cardiovasc Dis. 1989; 32(2):99-148. DOI: 10.1016/0033-0620(89)90022-4. View

Mitsnefes M, Stablein D . Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis. 2005; 45(2):309-15. DOI: 10.1053/j.ajkd.2004.11.006. View

Whitworth C, Fleming S, Cumming A, Morton J, Burns N, Williams B . Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int. 1994; 46(6):1528-32. DOI: 10.1038/ki.1994.437. View

Ozen S, Celik A, Alper H, Simsek D, Darcan S . Primary hyperparathyroidism in a young adult presenting with severe hypertension. J Pediatr Endocrinol Metab. 2010; 23(1-2):193-6. DOI: 10.1515/jpem.2010.23.1-2.193. View

Michael J, Groshong T, Tobias J . Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol. 1998; 12(1):40-2. DOI: 10.1007/s004670050400. View

Kincaid-Smith P . Malignant hypertension: mechanisms and management. Pharmacol Ther. 1980; 9(2):245-69. DOI: 10.1016/s0163-7258(80)80021-0. View

Geise J . The renin-angiotensin system and the pathogenesis of vascular disease in malignant hypertension. Clin Sci Mol Med Suppl. 1976; 3:19s-21s. View

10.

Katholi R, Winternitz S, Oparil S . Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat. Hypertension. 1981; 3(4):404-9. DOI: 10.1161/01.hyp.3.4.404. View

11.

Martin W, Spodick D, ZINS G . Pericardial disorders occurring during open-label study of 1,869 severely hypertensive patients treated with minoxidil. J Cardiovasc Pharmacol. 1980; 2 Suppl 2:S217-27. DOI: 10.1097/00005344-198000022-00016. View

12.

Armstrong E, Malone D . The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clin Ther. 2003; 25(1):1-18. DOI: 10.1016/s0149-2918(03)90003-8. View

13.

Mehta J, Lopez L . Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol. Arch Intern Med. 1987; 147(2):389-90. View

14.

Wiest D, Garner S, Uber W, Sade R . Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg. 1998; 115(4):890-7. DOI: 10.1016/S0022-5223(98)70371-X. View

15.

. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report):555-76. View

16.

Kwon S, Koo J, Lee S . Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol. 2001; 24(5):361-4. DOI: 10.1016/s0887-8994(01)00265-x. View

17.

Vonend O, Rump L, Ritz E . Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patients. Semin Dial. 2008; 21(4):326-30. DOI: 10.1111/j.1525-139X.2008.00456.x. View

18.

Fleming S . Malignant hypertension - the role of the paracrine renin-angiotensin system. J Pathol. 2000; 192(2):135-9. DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH674>3.0.CO;2-Q. View

19.

Abend N, Bonnemann C, Licht D . Status epilepticus secondary to hypertensive encephalopathy as the presenting manifestation of Guillain-Barré syndrome. Pediatr Emerg Care. 2007; 23(9):659-61. DOI: 10.1097/PEC.0b013e31814b2ddd. View

20.

Mohring J, Mohring B, Petri M, Haack D . Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol. 1977; 232(3):F260-9. DOI: 10.1152/ajprenal.1977.232.3.F260. View